Results 141 to 150 of about 16,174 (186)

Thromboprophylaxis in cancer surgery

2011
The presence of cancer, overt or occult, is thrombogenic to the individual. This has been recognised from the time of Armand Trousseau who, in 1865 [1], stated: “I have long been struck with the frequency with which cancerous patients are affected with painful oedema of the superior or inferior extremities, whether or not either was the seat of the ...
David Gozzard, David Perry
openaire   +1 more source

Thromboprophylaxis in a Pediatric Hospital

Current Problems in Pediatric and Adolescent Health Care, 2013
Venous thromboembolism (VTE) in children is an emerging area of focus in pediatric hospitals in recent years. Although VTE in hospitalized children occurs much less often than in adults, there are a significant number of children at risk of VTE who may benefit from thromboprophylaxis.
Mukta, Sharma, Shannon L, Carpenter
openaire   +2 more sources

Thromboprophylaxis and Neuraxial Anesthesia

Orthopedics, 2003
Abstract Spinal hematoma is a rare and potentially catastrophic complication of spinal or epidural anesthesia. Risk factors include traumatic needle/catheter placement, sustained anticoagulation in an indwelling neuraxial catheter, and catheter removal during therapeutic levels of anticoagulation.
openaire   +2 more sources

Thromboprophylaxis in Emergency Surgery

Haemostasis, 2009
Except for hip fracture surgery, emergency surgery has been only exceptionally studied concerning thromboprophylaxis. There are, however, several reasons to believe the frequency to be fairly high and that the patient group would be in need of prophylaxis.
D, Bergqvist, P A, Flordal, B, Friberg, J, Frisell, M, Hedberg, K G, Ljungström, T, Mätzsch, S, Törngren   +7 more
openaire   +2 more sources

Thromboprophylaxis in the Cancer Patient

Acta Haematologica, 2001
Cancer patients not undergoing treatment and without a history of venous thrombosis do not, as a general rule, require prophylaxis. However, venous thromboembolism is of sufficient magnitude in patients undergoing treatment for cancer for thromboprophylaxis to be routinely employed.
P A, Thodiyil, D C, Walsh, A K, Kakkar
openaire   +2 more sources

Thromboprophylaxis during chemotherapy: NO

Thrombosis Research, 2010
There is a wide range in rates of thrombosis in patients on chemotherapy reported in the literature. This is likely as a result of study design and case selection. The interest in primary prevention of venous thromboembolism in patients on chemotherapy has been rekindled by the association between antiangiogenic agents and thrombosis.
openaire   +2 more sources

Thromboprophylaxis in medical patients

Hospital Medicine, 2000
Recent clinical studies have confirmed that acutely ill medical patients are at substantial risk of venous thromboembolism, which can be reduced by thromboprophylaxis with low molecular weight heparin. These studies have resulted in approval of a low molecular weight heparin (enoxaparin) for the prophylaxis of venous thromboembolism in medical patients
openaire   +2 more sources

Thromboprophylaxis in cancer outpatients

Blood, 2008
In this issue of Blood, Khorana and colleagues report a simple and practical model for the prediction of symptomatic venous thrombosis after the initiation of chemotherapy in cancer outpatients.
openaire   +2 more sources

Thromboprophylaxis

Acta Orthopaedica Scandinavica, 1991
Antti Alho, Michael Rud Lassen, Lars C. Borris, Ulf Lucht   +3 more
openaire   +1 more source

Implementation of thromboprophylaxis guidelines.

Irish medical journal, 2013
Venous thromboembolism (VTE) remains one of the leading direct causes of maternal death. Risk factors for VTE and prophylaxis guidelines have been highlighted by the Royal College of Obstetricians and Gynaecologists (RCOG). A cross sectional study was completed in Cork University Maternity Hospital (CUMH) to determine pattern of VTE risk and compliance
Cregan, A, Higgins, JR, O’Shea, S
openaire   +2 more sources